3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
7
Multiple Myeloma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Smoldering Multiple Myeloma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Mantle-Cell
2
Down Syndrome
2
Lung Neoplasms
1
Leukemia, Plasma Cell
1
Leukemia, Biphenotypic, Acute
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
9
fludarabine
5
zanubrutinib
3
Vincristine
3
Rituximab
3
Doxorubicin
3
pirtobrutinib
2
cemiplimab
2
Specimen Handling
2
Prednisone
2
Magnetic Resonance Spectroscopy
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Etoposide
2
Dexamethasone
2
Cell- and Tissue-Based Therapy
2
tafasitamab
1
sodium-iodide symporter
1
selinexor
1
ruxolitinib
1
pomalidomide
1
polatuzumab vedotin
1
obinutuzumab
1
ibrutinib
1
glofitamab
1
etoposide phosphate
1
blinatumomab
1
acalabrutinib
1
X-Rays
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
auricularum
×
30 days
×
Clear all
No trials found.